An Update on Role of Matrix Metalloproteinases in the Central Nervous System in health along with various diseases –implications in treating brain tumours as well-A Systematic Review

Kulvinder Kochar Kaur
DOI: https://doi.org/10.61148/2766-8614/jccrcs/021
2021-02-22
Abstract:Matrix Metalloproteinases(MMP’s) represent zinc-endopeptidases possessing versatile actions in the human body both in health as well as disease.Earlier we reviewed the role of MMP’s in normal female reproductive system in health along with pregnancy as well as associated disorders .In the brain these MMP’s are key for tissue generation, neuronal network refashioning along with Blood Brain Barrier(BBB) integrity .Earlier reviews have concentrated only on 2 MMP’s namely MMP-2 as well as MMP-9 ,besides their part in one or few diseases.As our indepth understanding has grown with newer MMPs getting unraveled we decided to conduct a systematic review on MMPs in brain, BBB in neuroinflammation along with Central Nervous System( CNS) disease like multiple sclerosis(MS),cerebral aneurysm,stroke ,epilepsy, Parkinson’s disease(PD) ,Alzheimers disease(AD), along with brain cancer all related to neuroinflammation.Thus a systematic review was carried out using the pubmed and Google Scholar Search engine with the MeSH Terms; Matrix Metalloproteinases (MMP’s) along with their inhibitors,namely the, Tissue inhibitors of Matrix Metalloproteinases(TIMP); MS; cerebral aneurysm,stroke ,epilepsy, Parkinson’s disease(PD) ,Alzheimers disease(AD); brain cancer;Newer MMP inhibitors ;other therapies related to thesefrom 1900 to date in January 2021.We found a total of 4500 articles out of which we selected 220 articles for this review.No meta-analysis was done .Here we detail the update on MMP’s as well as how they aid in neuroinflammation,barrier leakage neurotoxicity ,demyelination,tumor growth,angiogenesis as well as metastasis.Till date other than doxyxcycline or minocycline no MMP Inhibitor has been approved by the FDA for clinical use .Further how honey bee products might be aiding in manipulation of MMPs along with newer MMP Inhibitors have been studies in human status epilepticus and more indepth studies are going on Knowing the significance of extracellular vesicles (ECV’s) in various diseases NDEVS can be targeted for developing specific therapies as in tumours with ECV’s overexpressing certain miR’s .
What problem does this paper attempt to address?